l carnitine oral solution L-Carnitine 3g/10ml (30%) Pediatric | Help SA Nutrex Research L-Carnitine 3000 (31

Japan study group of NAFLD (JSG-NAFLD)

ICAM 1, intercellular adhesion molecule 1

Both medications are considered to be class 2 federally controlled substances

Possible side effects include injection-site reactions, temporary skin irritation from topical use, and in rare cases, the "copper uglies" phenomenon

The effect of oral lysine administration is not clear due to intestinal malabsorption

In severe cases, the following symptoms may occur: derealization, depersonalization, hyperacusis, numbness and tingling of the extremities, hypersensitivity to light, noise and physical contact, hallucinations or epileptic seizures